Literature DB >> 23566991

Employment rights of people with diabetes: changing technology and changing law.

John W Griffin1.   

Abstract

Though the treatment of diabetes has advanced remarkably, the law and many employers have not always kept pace. New insulins, delivery systems, and monitoring systems give people with diabetes exceptional control over their blood sugar and virtually eliminate serious complications such as hypoglycemia and hyperglycemia. Changes in the law, particularly the Americans with Disabilities Act and its 2008 amendments, give people with diabetes greater rights and employment opportunities than ever before. Despite these advances, many employers continue to use blanket bans or ill-considered standards to bar people with diabetes. Efforts to break down these remaining barriers are ongoing through employee litigation and through the American Diabetes Association's collaboration with entities that set occupational standards.
© 2013 Diabetes Technology Society.

Entities:  

Mesh:

Year:  2013        PMID: 23566991      PMCID: PMC3737634          DOI: 10.1177/193229681300700209

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  3 in total

1.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

2.  Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.

Authors:  Julio Rosenstock; George Dailey; Massimo Massi-Benedetti; Andreas Fritsche; Zhengning Lin; Alan Salzman
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

3.  Diabetes and employment.

Authors:  John E Anderson; Michael A Greene; John W Griffin; Daniel B Kohrman; Daniel Lorber; Christopher D Saudek; Desmond Schatz; Linda Siminerio
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

  3 in total
  1 in total

Review 1.  From Individuals to International Policy: Achievements and Ongoing Needs in Diabetes Advocacy.

Authors:  Marisa E Hilliard; Sean M Oser; Kelly L Close; Nancy F Liu; Korey K Hood; Barbara J Anderson
Journal:  Curr Diab Rep       Date:  2015-09       Impact factor: 4.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.